HR=homologous recombination

Slides:



Advertisements
Similar presentations
Repairing Damages Bases 1. Mismatch repair (MMR) Dam methylase:MutS:
Advertisements

Non Homologous End Joining. Homologous Recombination Non Homologous End Joining.
 Chromosomes are coiled up “packages” of DNA.
Figure 1. DNA damage induced by 5-azadC
Volume 14, Issue 3, Pages (January 2016)
DNA Double-Strand Break Repair Inhibitors as Cancer Therapeutics
Office Hours (midterm #1)
Mus81 and Yen1 Promote Reciprocal Exchange during Mitotic Recombination to Maintain Genome Integrity in Budding Yeast  Chu Kwen Ho, Gerard Mazón, Alicia.
Targeting the DNA Damage Response in Cancer
Box Mutations in BRCA1/2 and Rad51 are associated with breast cancer
breast cancer 2, early onsetpro What does this protein make up or do?
Non-homologous End Joining (NHEJ)
Mutations + Recombination = Genetic Variation!!
Felix Dietlein, Lisa Thelen, H. Christian Reinhardt  Trends in Genetics 
Volume 14, Issue 3, Pages (January 2016)
Figure 2 Use of CRISPR/Cas9 for genome editing
The INO80 Complex Removes H2A
Figure 3 Endogenous repair of double-strand DNA breaks
Figure 1 Putative anticancer mechanisms of action of PARP inhibitors
RAG Proteins Shepherd Double-Strand Breaks to a Specific Pathway, Suppressing Error-Prone Repair, but RAG Nicking Initiates Homologous Recombination 
Presented by: Amber Lin & Yuan Zhao
SMARCAD1 Phosphorylation and Ubiquitination Are Required for Resection during DNA Double-Strand Break Repair  Sharmistha Chakraborty, Raj K. Pandita,
Volume 17, Issue 12, Pages (December 2016)
Saving the Ends for Last: The Role of Pol μ in DNA End Joining
Origin of Chromosomal Translocations in Lymphoid Cancer
Mus81 and Yen1 Promote Reciprocal Exchange during Mitotic Recombination to Maintain Genome Integrity in Budding Yeast  Chu Kwen Ho, Gerard Mazón, Alicia.
Take care of your chromosomes lest cancer take care of you
Volume 26, Issue 9, Pages (May 2016)
Volume 137, Issue 2, Pages (May 2015)
Recombination Mechanisms
DNA Repair in Prostate Cancer: Biology and Clinical Implications
DNA Double-Strand Break Repair Inhibitors as Cancer Therapeutics
Volume 46, Issue 2, Pages (April 2012)
When Genome Maintenance Goes Badly Awry
Genome Science Theme Seminar
Graeme Hewitt, Viktor I. Korolchuk  Trends in Cell Biology 
Mutations + Recombination = Genetic Variation!!
CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
Therapeutic editing of hepatocyte genome in vivo
Itai M. Pessach, MD, PhD, Luigi D. Notarangelo, MD 
CRISPR genome-editing: A medical revolution
Chp.13: Meiosis & Sexual Reproduction
Current Progress in Therapeutic Gene Editing for Monogenic Diseases
Cancer Susceptibility and the Functions of BRCA1 and BRCA2
(A) Poly(ADP-ribosyl)ation often referred to as PARylation is a post-translational protein modification catalyzed by poly(ADP-ribose) polymerases [PARPs].
Somatic Hypermutation of Immunoglobulin Genes
DNA Double-Strand Breaks Come into Focus
The INO80 Complex Removes H2A
The Fuss about Mus81  James E Haber, Wolf-Dietrich Heyer  Cell 
The DNA Damage Machinery and Homologous Recombination Pathway Act Consecutively to Protect Human Telomeres  Ramiro E. Verdun, Jan Karlseder  Cell  Volume.
Fanconi Anemia (Cross)linked to DNA Repair
Marie Frank-Vaillant, Stéphane Marcand  Molecular Cell 
Chromosomal Rearrangements Occur in S
Early Decision Cell Volume 117, Issue 1, Pages 9-15 (April 2004)
The role of microhomology in genomic structural variation
DNA repair: Rad52 – the means to an end
The DNA Damage Response: Making It Safe to Play with Knives
Chandan Shee, Janet L. Gibson, Susan M. Rosenberg  Cell Reports 
Graeme Hewitt, Viktor I. Korolchuk  Trends in Cell Biology 
Allyson M Holmes, James E Haber  Cell 
Homology Requirements and Competition between Gene Conversion and Break- Induced Replication during Double-Strand Break Repair  Anuja Mehta, Annette Beach,
Gene editing by CRISPR/Cas9 for gene inactivation and targeted sequence replacement. Gene editing by CRISPR/Cas9 for gene inactivation and targeted sequence.
XRCC3 Controls the Fidelity of Homologous Recombination
At Loose Ends: Resecting a Double-Strand Break
Markus Löbrich, Penny Jeggo  Trends in Biochemical Sciences 
Are Mouse Telomeres Going to Pot?
Michael J. McIlwraith, Stephen C. West  Molecular Cell 
The DNA Damage Response: Making It Safe to Play with Knives
Gene Amplification: Yeast Takes a Turn
Nuclease Target Site Selection for Maximizing On-target Activity and Minimizing Off- target Effects in Genome Editing  Ciaran M Lee, Thomas J Cradick,
Presentation transcript:

HR=homologous recombination NHEJ=Non-homologous end joining In HR, 100-1000 bases removed to make long 3’ overhang that invades copy on sister chromatid. Or other chromosome? (unlikely due to expected slow kinetics). This suggests greater dependence on RNR for HR than NHEJ (but what about salvage of what was just taken out? Or salvage imported in from the outside). If 25-mer defines position in genome uniquely, this implies that cells use much bigger sequences to make absolutely sure the invasion is in the right place, consistent with HR repair being a high fidelity route.

NHEJ deficient NHEJ deficient NHEJ wt HR wt HR wt HR deficient rad51-/- HR deficient brac2-/- NHEJ deficient NHEJ deficient NHEJ wt HR wt HR wt dNTPs needed by HR NHEJ also important in S-phase We conclude that blocking the ability to generate dNTPs de novo does not significantly impact how well NHEJ proficient, G1/G0 enriched cells repair IR-generated DSBs, consistent with our predictions. [HU] may be low enough that NHEJ is not impacted; higher [HU] may have killed both routes and this may explain why 200 uM was used in this study.

And what is left, HR, depends on dNTPs NHEJ is important HR not that important Same data as previous Table rad51 Interacts with Lig4 = Pol alpha/delta inhibitor

Rad51 focus positive cells were apparent in Xrs6 cells but not K1 cells, indicating HR is employed for DSB repair in G1 cells only when NHEJ is not available (Fig. 2C) Feedforward says don’t try HR without dNTPs Less so without DNA pol Note HR much slower than NHEJ for pure IR

breaks, only which pathway (HR or NHEJ) they use to repair them p53R2 Overexpression does not help if NHEJ is working fine in wild type cells. p53R2 is overexpressed p53R2 Overexpressed Helps cells with only HR active, i.e. NHEJ minus. Conclude: differences in RNR activity does not significantly determine if cells successfully repair double strand breaks, only which pathway (HR or NHEJ) they use to repair them

Abstract, last line: “This may explain in part why G1/G0 cells, which have reduced ribonucleotide reductase activity, rely more on NHEJ for DSB repair.” More likely NHEJ is used in G1 due to slow kinetics of HR, supported by Fig. 2 In Intro: As a consequence, RNR activity rises in early S, and falls after G2 – a fluctuation that correlates well with the extent cells perform HR. Fails to say that S to G2 also lines up with sister chromatids being there, early S would discriminate, i.e. if HR is very active in early S then they are right. NHEJ’s ability to sustain efficient repair regardless of the activity of the de novo pathway is thus a strong rationale for using a repair pathway suggested to be intrinsically more error prone than the alternative (HR). I disagree here, I think it is for faster kinetics.